From: Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors
Group I (4 × 3.8 Gy)
Group II (2 × 7.2 Gy)
Fatal hemoptysis
18.3%
12.2%
Other reason than tumor progression
13.3%
8.5%
Local problems
20%
32.9%
Unknown
15%